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Primary leiomyosarcoma of the inferior vena
cava: Reports of infrarenal and suprahepatic
caval involvement
Michael N. Tameo, MD, Keith D. Calligaro, MD, Leah Antin, MSN, ACNP-BC, and
Matthew J. Dougherty, MD, Philadelphia, Pa
We report two cases of primary inferior vena cava (IVC) leiomyosarcoma. The first patient was a 60-year-old female who
presented with abdominal pain. The patient was initially diagnosed with a retroperitoneal sarcoma that may have involved
the right renal vessels and the IVC. The Vascular Surgery Service was consulted intra-operatively when it became evident
that the IVC was primarily involved. The patient was treated with total en-bloc excision of the infrarenal IVC tumor with
concomitant interposition polytetrafluoroethylene (PTFE) graft caval replacement. The second patient was a 58-year-old
female who presented with general malaise and anemia. This tumor began in the distal infrarenal IVC and extended
cephalad to the suprahepatic IVC, ending approximately 2 cm below the right atrium. Intrapericardial IVC clamping was
required for cephalad control in this patient, who was then treated with excision of the tumor and concomitant
interposition PTFE graft caval replacement with reimplantation of the right renal vein. A review of this rare tumor is
presented. (J Vasc Surg 2010;51:221-4.)Primary tumors of the inferior vena cava (IVC) are rare,
with leiomyosarcoma (LMS) representing the vast majority
(95%). Greater than 50% of all vascular LMSs occur in the
IVC.1 Prognosis is often poor due to advanced stage at
diagnosis. Surgical excision of the tumor and affected IVC
with negative margins is the only treatment shown to
improve survival.1-3 Reconstruction of the IVC and other
involved vessels is often required. There is no proven role
for adjuvant treatment, and recurrence is common. We
present two cases of primary IVC LMS, one confined to the
infrarenal IVC and one extending to the suprahepatic IVC,
and discuss treatment options and controversies.
CASE 1
A 60 year-old female presented with right-sided abdomi-
nal pain. Physical examination revealed tenderness with mild
firmness in the right upper quadrant andmild edema of lower
extremities. Computed tomography (CT) revealed a retroper-
itoneal tumor in the right upper quadrant with questionable
involvement of the right renal vessels and the IVC.
The patient was diagnosed with a retroperitoneal sar-
coma by a general surgeon who scheduled surgical excision.
A midline incision was performed and The Vascular Surgery
Service was consulted intraoperatively when it became evident
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would be necessary for potentially curative resection.
The tumor involved the infrarenal portion of the IVC
and exhibited both intra- and extra-luminal growth. After
the IVC was isolated en-bloc, intravenous heparin was
administered. There was enough normal IVC below the
renal veins to achieve proximal control by clamping the
IVC just inferior to their origin. Distal control was obtained
by clamping the IVC just proximal to the iliac bifurcation.
The tumor was resected en-bloc along with the affected
IVC. The resulting defect was repaired using standard-wall
polytetrafluoroethylene (PTFE) interposition graft sutured
in an end-to-end fashion. A large right gonadal vein was
salvaged as it inserted into the IVC just cephalad to the
proximal anastomosis. Completion venogram showed a
widely patent graft, IVC, and renal veins. Pathologic exam-
ination of the specimen revealed LMS with intra- and
extra-luminal IVC growth and negative margins.
Postoperatively, the patient was placed on low-dose
heparin and warfarin therapy. Adjuvant therapy was not
administered. The patient was discharged to home on
postoperative day five and was doing well 16 months post-
operatively. Follow-up duplex ultrasound has shown
chronic laminar thrombus in the posterior wall of the graft
causing mild (less than 30%) stenosis. The patient remains
on warfarin therapy to help maintain graft patency and is
followed up every six months with serial duplex ultra-
sounds, as well as CT scans to monitor for recurrence.
CASE 2
A 58-year-old female presented with general malaise
and anemia. A CT of the abdomen showed a large IVC
tumor extending cephalad from the infrarenal to the supra-
hepatic portion of the IVC, approximately 2.0 cm from the
right atrium (Fig 1).
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incision, medial visceral rotation, circumferential division
of the diaphragm, and medial reflection of the liver. The
liver was dissected free from the IVC to the hepatic vein
confluence, where dense inflammatory tissue was encoun-
tered. Tumor growth was intra-luminal in the cephalad
portion and both intra- and extra-luminal in the caudal
portion. The patient was then systemically heparinized.
The distal IVC and right renal vein were clamped and the
left renal vein was divided and oversewn. A Pringle maneu-
ver was used to reduce flow into the liver and the intraperi-
cardial IVC was clamped. The hepatic vein confluence was
then clamped. Neither veno-venous bypass nor circulatory
arrest were necessary since mean arterial pressure was ade-
quately maintained with liberal administration of intrave-
nous fluids. The tumor and IVC were then resected. The
proximal anastomosis was performed by anastomosing a
ringed PTFE graft to the beveled proximal IVC, which
Fig 1. Computed tomography (CT) image showing Case 2 IVC
tumor within liver.
Fig 2. Intra-operative photo showing Case 2 reimplanted right
renal vein and distal anastomosis.incorporated the orifices of the hepatic veins. The clampson the intrapericardial IVC, hepatic veins, and portal vessels
were removed to back-flush the cephalad IVC and a clamp
was then placed on the proximal graft. The distal anasto-
mosis was performed just cephalad to the iliac vein conflu-
ence. The right renal vein was then reimplanted as a Carrel
patch and the graft was covered with an omental flap (Fig
2). Pathologic examination of the specimen revealed LMS
with intra- and extra-luminal IVC growth and negative
margins.
Postoperatively, the patient was placed on low-dose
heparin and warfarin therapy. Adjuvant therapy was not
given. She was discharged to home on postoperative day
seven and was doing well four months postoperatively.
Follow-up duplex ultrasound has shown a widely patent
graft. The patient remained on warfarin therapy to help
maintain graft patency. She will be followed up every six
months with serial duplex ultrasounds, as well as CT scans
to monitor for recurrence.
DISCUSSION
Primary IVC sarcoma is very unusual, with leiomyosar-
coma (LMS) representing the large majority (95%) of tu-
mors. More than half of all vascular LMS occurs at the IVC.
Vascular LMS represents 2% of all LMSs and 0.5% of all soft
tissue sarcomas.1,4 IVC LMS is a malignant tumor of
mesenchymal origin that develops from smooth muscular
fibers of the tunica media.2 Perl first described it in 1871
and the first surgical resection was in 1928 by Mechior.5,6
LMS of the IVC is more than four times more common
among women and is most commonly diagnosed in the
sixth decade of life.3
IVC LMS has a slow rate of growth and can remain
asymptomatic for some time, causing diagnosis to be de-
layed until advanced stages, when prognosis is poor. Tumor
growth within the IVC is intra-luminal in 5%, extra-luminal
in 62%, and both intra- and extra-luminal in 33%.7 His-
topathological features are identical to those found in LMS
of other sites. There is no standardized histological grading
system for IVC tumors; however, some authors have rec-
ommended using the criteria for retroperitoneal LMSs,
which is based on mitotic count.8 Additionally, clinical
staging has been suggested as follows: occlusive, which
may present as a mass, edema, or thrombophlebitis; non-
occlusive, when asymptomatic or an incidental finding; and
terminal, when there are features of distant metastases. IVC
LMS primarily metastasizes to the lung, liver, and occasion-
ally to bone and brain.9,10
The presentation of LMS depends on its location along
the IVC, which can be divided into three segments for this
purpose. Segment I (lower) is below the renal veins and is
involved in 36% of cases. Typical presenting symptoms for
IVC LMS in this segment may include lower extremity
edema, deep venous thrombosis, abdominal pain, and pal-
pable mass. Segment II (middle) is from the hepatic veins
to the renal veins and is involved in 44% of cases. Symptoms
in this region may include abdominal pain, nephrotic syn-
drome, and renal hypertension. Segment III (upper) is
from the right atrium to the hepatic veins, is involved in
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Budd-Chiari syndrome, and cardiac arrhythmias.2,3,11,12
Diagnosis of IVC LMS is often incidental or at autopsy.
When symptoms are present, CT or magnetic resonance
imaging (MRI) are useful to determine the extent of tumor
involvement. Definitive diagnosis can be made by intrave-
nous, fluoroscopic-, CT-, or duplex-guided biopsy, or by
surgical excision. Extra-luminal extension of IVC LMS can
be mistaken for masses of adjacent organs and differential
diagnoses should include primary tumors of these organs.
Prognosis is better for tumors involving the middle
segment of the IVC compared with the upper segment; for
growth from within the media compared with growth from
the intima; and for absence rather than presence of a
palpable mass. Budd-Chiari Syndrome, lower extremity
edema, or IVC occlusion are poor prognostic indicators as
well. The presence of abdominal pain (which occurs earlier
in the middle segment due to rich innervation of the
adjacent organs) portends a better prognosis. Patient age,
gender, tumor size, grade, and node status do not influence
survival. Surgical margin status, however, does impact sur-
vival, with no patients surviving to five years with positive
margins, compared with 68% in those with negative mar-
gins in one study.4,12,13
Surgical resection with negative margins, as was the
case with both of our patients, has been shown to be the
only treatment that improves survival.1,2,3 Tumors involv-
ing the lower segment are best treated with total excision of
the tumor and involved portion of the IVC and either
primary IVC closure, patch angioplasty with autologous
vein or prosthetic patch, or replacement with interposition
PTFE or banked venous homograft.14 If thrombus is
present, then the resection should be carried to the proxi-
mal level of the thrombus, as clamping across thrombus can
cause pulmonary embolism. If the IVC is acutely occluded
or partially occluded, then graft should be used. However,
if chronically occluded with many collaterals and no in-
volvement of the renal veins, the IVC can be ligated if
pressure measurements indicate the absence of distal ve-
nous hypertension.13 For middle segment tumors, the res-
toration of renal venous flow must be considered. The left
renal vein may be ligated due to collateral flow from the
gonadal, adrenal, and lumbar veins. We reported that left
renal vein stump pressure may be measured to help deter-
mine how well ligation will be tolerated.15 Flow from the
right renal vein, however, must be preserved. This can be
accomplished with re-implantation into the IVC, interpo-
sition graft to the IVC, reconstruction using the gonadal
vein, or autotransplantation of the kidney to the right iliac
fossa.7 Nephrectomy is performed if the renal hilum, kid-
ney, or ureter are involved. If right nephrectomy is per-
formed then the left renal vein must be re-implanted. For
upper segment tumors or middle segment tumors that
involve the hepatic veins, several techniques can be em-
ployed. Total vascular exclusion of the liver, veno-venous
shunting, cardiopulmonary bypass, or circulatory arrest
with deep hypothermia can be used. However, in the vast
majority of patients with suprarenal tumors, as in ours,liberal intravenous fluid administration will usually suffice
and these adjunctive maneuvers are usually not necessary.
Tumors in this region often require a thoracoabdominal
approach or a combined laparotomy and sternotomy.16
Several technical considerations warrant discussion.
First, when PTFE is used, some suggest that externally
supported PTFE prevents collapse from respiratory com-
pression and from surrounding structures, while others
believe that it incorporates poorly and predisposes to
entero-prosthetic fistula formation with the duodenum.17
We used a non-supported PTFE graft in the first case and a
ringed graft in the second case and placed omental flaps in
both cases to prevent fistula formation.
Under-sizing of the PTFE has been recommended
with the rationale that the resulting increase in blood flow
velocity within the graft might reduce thrombotic risk.18
Others recommend a larger diameter graft, as PTFE tends
to form a thick pseudo-intima that may result in obstruc-
tion.19 We used larger (24 mm and 20 mm) grafts in our
patients.
Creation of an arterio-venous fistula (AVF) either be-
tween the aorta and IVC or iliac vein, or between the
femoral vessels has been advocated. AVF creation is theo-
rized to improve patency and prevent the need for antico-
agulation by elevating blood flow velocity.16 However,
complications such as limb edema and congestive heart
failure have been attributed to AVFs. We did not create an
AVF fistula in our patients.
Finally, long-term postoperative anticoagulation is rec-
ommended by some authors to prevent thrombosis, while
others report acceptable patency without warfarin the-
rapy.16,17 We used intravenous heparin bridging with oral
warfarin therapy in our patients.
Following curative resection of the tumor, recurrence
rates have been reported to be as high as 57% with five-year
survival of 50% in a large series by Mingoli et al.20 Adjuvant
treatment with radiation or chemotherapy has not been
proven to improve survival and was not used in our cases.
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